Construction And Characterization of a Conditionally Active Construct of The Insulin-Regulated Forkhead Transcription Factor FKHR

Summary

Insulin is known to inhibit glucose-6-phosphatase gene expression through PI 3-kinase/PKB mediated phosphorylation and inactivation of the forkhead transcription factor FKHR, which is a potent transactivator of the glucose-6-phosphatase gene. To study the function and regulation of the transcription factor FKHR in hepatic cells, we constructed a hydroxytamoxifen-inducible version of FKHR by fusing a part of the hormone binding domain of the estrogen receptor (ER) to the C-terminus of FKHR (FKHR-ER). In HepG2-cells transiently transfected with plasmids encoding the FKHR-ER fusion protein and a glucose-6-phosphatase reporter construct, hydroxytamoxifen induced a marked induction of glucose-6-phosphatase promoter activity, whereas no effect was observed in control cells. We next generated a H4IIEC3 rat hepatoma cell line stably expressing both FKHR-ER and a glucose-6-phosphatase promoter-based reporter construct. After 2h stimulation with hydroxytamoxifen, the promoter activity was stimulated 3-5 fold, and continued to increase up to 100-fold after 15 h. The response was half maximal at 0.5 μM hydroxytamoxifen. Insulin (1 nM) decreased the hydroxytamoxifen induced promoter activity by about 70% of the maximal response. This cell system can be used for (1) the identification of FKHR dependent genes and for (2) high throughput screening (HTS) of agents affecting the activity of FKHR and its regulation by insulin.

Abbreviations used: FKHR, forkhead in rhabdomyosarcoma; G6Pase, glucose-6-phosphatase; PKB, protein kinase B; PI 3-kinase, phosphatidyl-inositol 3-kinase; IRU, insulin-responsive unit; Tx, 4-hydroxytamoxifen, ER, estrogen receptor; HBD, hormone binding domain

Insulin - FKHR - Glucose-6-phosphatase - Estrogen receptor - Hydroxytamoxifen

References

• 1 Barthel A, Okino S T, Liao J, Nakatani K, Li J, Whitlock J P, Roth R A. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1.  J Biol Chem. 1999;  274 20281-20286
• 2 Barthel A, Schmoll D, Krüger K D, Bahrenberg B, Walther R, Roth R A, Joost H G. Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells.  Biochem Biophys Res Commun. 2001;  285 897-902
• 3 Biggs W H, Meisenhelder J, Hunter T, Cavenee W K, Arden K C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.  Proc Natl Acad Sci USA. 1999;  96 7421-7426
• 4 Brunet A, Bonni A, Zigmond M J, Lin M Z, Juo P, Hu L S, Anderson M J, Arden K C, Blenis J, Greenberg M E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor.  Cell. 1999;  96 857-868
• 5 Chou J Y, Mansfield B C. Molecular genetics of type 1 glycogen storage diseases.  Trends in Endocrinology and Metabolism. 1999;  10 104-113
• 6 Clore J N, Stilman J, Sugarman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes.  Diabetes. 2000;  49 969-974
• 7 Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells.  Science. 1995;  268 1766-1769
• 8 Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.  J Biol Chem. 1999;  274 17184-17192
• 9 Hall R K, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, Granner D K. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor binding protein-1 gene expression by insulin.  J Biol Chem. 2000;  275 30169-30175
• 10 Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M. Differential modulation of cyclin gene expression by myc.  Proc Natl Acad Sci USA. 1993;  90 3685-3689
• 11 Kohn A D, Barthel A, Kovacina K S, Boge A, Wallach B, Summers S A, Birnbaum M J, Scott P H, Lawrence J C, Roth R A. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt.  J Biol Chem. 1998;  273 11937-11943
• 12 Liao J, Barthel A, Nakatani K, Roth R A. Activation of protein kinase B/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene.  J Biol Chem. 1998;  273 27320-27324
• 13 Littlewood T D, Hacock D C, Danielian P S, Parker M G, Evan G I. A modified estrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.  Nucleic Acids Res. 1995;  23 1686-1690
• 14 Rena G, Guo S, Cichy S C, Unterman T G, Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.  J Biol Chem. 1999;  274 17179-17183
• 15 Scherrer L C, Picard D, Massa E, Harmon J M, Simons S S, Yamamoto K R, Pratt W B. Evidence that the hormone binding domain of steroid receptors confers hormonal control on chimeric proteins by determining their hormone-regulated binding to heat-shock protein 90.  Biochemistry. 1993;  32 5381-5386
• 16 Schmoll D, Wasner C, Hinds C J, Allan B B, Walther R, Burchell A. Identification of a cAMP response element within the glucose-6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells.  Biochem J. 1999;  338 457-463
• 17 Schmoll D, Walker K S, Alessi D R, Grempler R, Burchell A, Guo S, Walther R, Unterman T G. Regulation of glucose-6-phosphatase gene expression by protein kinase Bα and the forkhead transcription factor FKHR.  J Biol Chem. 2000;  275 36324-36333